Pricing and Reimbursement of Next Generation Diagnostics in the United States

Decision Resources
December 13, 2007
20 Pages - SKU: DECR1635637
License type:
Table of Contents Related Reports
Countries covered: United States

Next-generation diagnostics promise to offer an enhanced ability to diagnose disease and to provide moretargeted drug therapy to patients. However, for manufacturers of these new technologies, navigating the current pricing and reimbursement structure of major payers in the United States is a tremendous challenge.

In this report, Catherine Shaffer, M.Sc., lends her expertise in biotechnology to provide a comprehensive overview of current next-generation diagnostics. Neil Grubert, M.A., director of pricing and reimbursement research at Decision Resources, Inc., presents a thorough analysis of the current U.S. pricing and reimbursement environment for diagnostics with a special focus on Medicare policies. The discussion includes strategies that diagnostics companies may employ in the quest to bring products to market successfully and to achieve a favorable reimbursement status.

Get the Answers You Need to Shape Your Strategy
  • Next-generation diagnostic tests build upon existing molecular technologies, resulting in either a greatly en hanced version of older technology or in a completely new approach. Which novel diagnostics have received approval, and what improvements do they offer over existing technologies?
  • The greatest difficulty in entering the market with a novel diagnostic test is navigating the existing pricing and reimbursement structure of the major payers. How do Medicare and private payers determine coverage for diagnostic tests? Which private payer has the most transparent coverage policies for diagnostics?
  • Manufacturers of diagnostic tests must meet rigorous requirements for patient outcomes data and showcase a test's clinical value before payers, particularly Medicare, will approve reimbursement. How has Genomic Health successfully secured coverage for its product Oncotype DX, a test that quantifi es the likelihood of recurrence of breast cancer?
  • Similar to the controversy surrounding personalized medicine, which calls into question the notion of market restriction with the use of targeted therapies, there is limited fi nancial incentive to invest in developing a diagnostic test. What strategies can companies employ to increase the uptake of a diagnostic test during commercialization?
Scope
  • Birth of next-generation diagnostics: overview and description of diagnostic tests that improve upon existing immunoassay and nucleic acid testing (NAT) technologies.
  • Next-generation diagnostics approved since 2001: coverage of select diagnostics for indications such as drug metabolism, chemotherapy side effects, oncology, cystic fi brosis, and HIV.
  • Current pricing and reimbursement environment for diagnostics: path to market, challenges of collecting health outcomes data, and commercialization strategies.
  • Medicare's role in the reimbursement of diagnostics: description of the agency's policies in determining coding, coverage, and payment levels.
  • Private payers' role in the reimbursement of diagnostics: overview of private payers' policies.
  • Outlook: a look at the future pricing and reimbursement environment for next-generation diagnostics.
Please note, the PDF e-mail from publisher version of this report is for a global site license.


More United States General In Vitro Diagnostics Reports

Strategic Implications of Technological and Market Trends for the US Diagnostics Industry by Venture Planning Group
How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing ...

Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market by Venture Planning Group
How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing ...

The 2012 Therapeutic Drug Monitoring Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment by Venture Planning Group
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; ...

The 2012 Immunoprotein Diagnostics Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment by Venture Planning Group
During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent ...

The 2012 Hepatitis Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


General In Vitro Diagnostics Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!